WEBVTT

00:00:00.000 --> 00:00:02.730
Welcome to the Deep Dive! Today, we're tackling

00:00:02.730 --> 00:00:05.910
a really pivotal question in pharmaceutical development.

00:00:06.669 --> 00:00:09.390
How are parallel synthesis and automated reactor

00:00:09.390 --> 00:00:12.550
systems changing the game? Basically, how fast

00:00:12.550 --> 00:00:15.570
can we create new medicines now? It's a critical

00:00:15.570 --> 00:00:18.010
area, definitely. So you, our listener, are going

00:00:18.010 --> 00:00:21.570
to get a clear understanding of how these advanced

00:00:21.570 --> 00:00:24.510
tools, and also things like small scale experiments,

00:00:24.750 --> 00:00:27.250
computer control. Statistical design, too. Right.

00:00:27.309 --> 00:00:29.250
And statistical design, how all that is driving

00:00:29.250 --> 00:00:31.170
efficiency, getting therapies to pay. patients

00:00:31.170 --> 00:00:33.390
faster. Yeah, and you might have noticed things

00:00:33.390 --> 00:00:36.409
like the special feature section, new technologies

00:00:36.409 --> 00:00:38.869
and process research. There's real interest here.

00:00:39.250 --> 00:00:42.909
Exactly. So our focus today is pretty sharp.

00:00:43.649 --> 00:00:45.929
How do these approaches actually optimize the

00:00:45.929 --> 00:00:48.130
development process and improve scalability?

00:00:48.289 --> 00:00:50.570
And ultimately shrink that timeline for new drugs.

00:00:50.829 --> 00:00:54.219
Okay. So where do we start? Parallel synthesis.

00:00:54.899 --> 00:00:57.399
Let's. It's fascinating how these technologies

00:00:57.399 --> 00:01:00.219
sort of converge. Parallel synthesis at its heart,

00:01:00.299 --> 00:01:01.840
it just means making lots of different compounds

00:01:01.840 --> 00:01:03.820
at the same time. Instead of one after the other.

00:01:04.159 --> 00:01:08.120
Precisely. Not that old linear way. Imagine generating

00:01:08.120 --> 00:01:10.700
whole libraries of molecules side by side. And

00:01:10.700 --> 00:01:12.620
then you combine that with automated reactors.

00:01:12.840 --> 00:01:15.099
Yes. Yes. And these are often small systems,

00:01:15.359 --> 00:01:17.719
our source has mentioned, like 10 to 100 milliliter

00:01:17.719 --> 00:01:21.549
scales. tiny, really. But they give you incredibly

00:01:21.549 --> 00:01:24.189
precise control. You can monitor lots of different

00:01:24.189 --> 00:01:26.989
reactions happening all at once. Okay, let's

00:01:26.989 --> 00:01:29.170
dig a bit deeper there. So moving from sequential

00:01:29.170 --> 00:01:32.849
to parallel, what's the immediate hit for someone

00:01:32.849 --> 00:01:34.870
trying to find a new drug? Well, the biggest

00:01:34.870 --> 00:01:37.709
immediate impact is speed, a dramatic acceleration,

00:01:37.870 --> 00:01:39.790
especially in those early discovery stages. Right.

00:01:40.129 --> 00:01:42.450
You can suddenly screen a much, much broader

00:01:42.450 --> 00:01:45.150
range of conditions. Try different catalysts,

00:01:45.250 --> 00:01:47.530
temperatures, solvents. All at once. All at once.

00:01:47.769 --> 00:01:50.450
So the scope of your experimentation just explodes.

00:01:51.109 --> 00:01:53.209
And you get a richer understanding of the chemistry

00:01:53.209 --> 00:01:56.370
involved in way less time. So it's not just saving

00:01:56.370 --> 00:01:59.250
lab hours. Yeah. potentially changing what's

00:01:59.250 --> 00:02:02.290
even possible. Absolutely. It can alter the economics,

00:02:02.950 --> 00:02:05.150
make research that was maybe too slow or expensive

00:02:05.150 --> 00:02:08.509
suddenly viable. That makes sense. Now, we know

00:02:08.509 --> 00:02:11.750
early drug development often throws up some tricky

00:02:11.750 --> 00:02:14.889
challenges, doesn't it? Always. Like one source

00:02:14.889 --> 00:02:17.590
mentioned, poor water solubility. Lots of promising

00:02:17.590 --> 00:02:20.409
candidates have that issue. How do these parallel

00:02:20.409 --> 00:02:22.770
techniques help there? That's a great example

00:02:22.770 --> 00:02:26.449
because you can quickly make and test lots of

00:02:26.449 --> 00:02:29.689
variations analogs of your lead compound. Tweaking

00:02:29.689 --> 00:02:32.490
the structure slightly each time. Exactly. You

00:02:32.490 --> 00:02:35.330
systematically explore changes designed specifically

00:02:35.330 --> 00:02:38.129
to improve properties like solubility. Make a

00:02:38.129 --> 00:02:40.590
small change, test it quickly, see the impact.

00:02:40.909 --> 00:02:43.550
You navigate that chemical space much more efficiently.

00:02:44.189 --> 00:02:47.370
So it's like this engine for exploring possibilities

00:02:47.370 --> 00:02:49.819
around a starting point. trying to find that

00:02:49.819 --> 00:02:51.699
sweet spot, the right properties for a drug.

00:02:51.819 --> 00:02:53.939
That's a good way to put it. An efficient engine

00:02:53.939 --> 00:02:56.080
for molecular exploration. And you mentioned

00:02:56.080 --> 00:02:58.000
working small scale. Why is that so important,

00:02:58.180 --> 00:03:01.020
the miniaturization? Oh, it's huge for efficiency.

00:03:01.740 --> 00:03:03.919
Resource efficiency. You need way less starting

00:03:03.919 --> 00:03:06.439
material. You generate minimal waste. Which lets

00:03:06.439 --> 00:03:08.800
you do more experiments. Far more, yeah. Yeah.

00:03:09.080 --> 00:03:11.710
And critically, the data you get. from these

00:03:11.710 --> 00:03:14.669
small parallel reactors, it can actually be quite

00:03:14.669 --> 00:03:16.889
representative of what happens on a larger scale.

00:03:16.969 --> 00:03:19.210
Really? Yeah, one of the sources really emphasizes

00:03:19.210 --> 00:03:22.949
that. So you gain crucial insights without the

00:03:22.949 --> 00:03:26.389
massive cost and material needs of big trials.

00:03:27.169 --> 00:03:29.430
Interesting. So insights from tiny experiments

00:03:29.430 --> 00:03:33.889
can actually guide the scale -up process. Are

00:03:33.889 --> 00:03:37.979
there limits? pitfalls maybe? That's a very important

00:03:37.979 --> 00:03:40.620
question. It's not always a perfect one -to -one

00:03:40.620 --> 00:03:43.020
translation of course. Okay. Things like say

00:03:43.020 --> 00:03:45.460
heat transfer or mixing behave differently in

00:03:45.460 --> 00:03:47.680
a huge vat versus a tiny vial. That's physics.

00:03:47.819 --> 00:03:50.860
Right. But having that fundamental understanding

00:03:50.860 --> 00:03:53.719
early on optimal conditions, potential impurities,

00:03:54.180 --> 00:03:56.340
reaction kinetics, it's incredibly valuable.

00:03:56.439 --> 00:03:58.300
It means you make much more informed decisions

00:03:58.300 --> 00:04:00.680
when you do scale up. So you avoid major surprises

00:04:00.680 --> 00:04:03.860
later, less costly rework. Exactly. You reduce

00:04:03.860 --> 00:04:05.979
the likelihood of hitting big problems. Think

00:04:05.979 --> 00:04:08.780
about that example from one of the sources. Synthesizing

00:04:08.780 --> 00:04:11.340
over 500 -quinoxyline derivatives. For anti -TB

00:04:11.340 --> 00:04:13.719
drugs, yeah. Right. You just couldn't explore

00:04:13.719 --> 00:04:17.100
that much chemical space practically or affordably

00:04:17.100 --> 00:04:20.139
without doing it small scale in parallel. 500,

00:04:20.279 --> 00:04:23.189
wow. That really hammers home the point. And

00:04:23.189 --> 00:04:27.089
didn't that same source mention modifying exocyclic

00:04:27.089 --> 00:04:29.889
groups? Yes, for fighting drug -resistant TB.

00:04:30.129 --> 00:04:32.589
Where even tiny structural changes had big effects

00:04:32.589 --> 00:04:34.889
on activity. Precisely. Like the position of

00:04:34.889 --> 00:04:37.370
one methyl group. That level of fine -tuning

00:04:37.370 --> 00:04:40.350
is perfect for these automated parallel setups.

00:04:40.629 --> 00:04:43.180
You make the tweak, you test it fast. A very

00:04:43.180 --> 00:04:45.920
efficient way to optimize how the molecule hits

00:04:45.920 --> 00:04:48.240
its target. You got it. OK, let's shift to the

00:04:48.240 --> 00:04:50.639
computers. The control and automation side. It's

00:04:50.639 --> 00:04:52.860
not just doing many things at once. It's the

00:04:52.860 --> 00:04:55.060
way they're done, right? The precision. Absolutely

00:04:55.060 --> 00:04:57.939
critical. Computer control gives you incredibly

00:04:57.939 --> 00:05:00.480
accurate handling of all the key parameters.

00:05:00.939 --> 00:05:03.509
Temperature. stirring speed, how fast you add

00:05:03.509 --> 00:05:06.569
reagents. Very tight control. Very tight. Which

00:05:06.569 --> 00:05:09.629
leads to much more consistent reproducible experiments

00:05:09.629 --> 00:05:12.129
compared to, well, doing it all by hand. And

00:05:12.129 --> 00:05:14.850
that consistency must be vital for trusting the

00:05:14.850 --> 00:05:17.689
data you get. Oh, absolutely. Plus, these systems

00:05:17.689 --> 00:05:20.490
usually log data automatically. They monitor

00:05:20.490 --> 00:05:24.009
progress, yield, impurities, generating this

00:05:24.009 --> 00:05:26.089
huge amount of data that's instantly stored and

00:05:26.089 --> 00:05:28.629
ready for analysis. Much easier than scribbling

00:05:28.629 --> 00:05:31.089
in a lab notebook and trying to spot trends later.

00:05:31.259 --> 00:05:35.759
So speed, efficiency, tons of high quality, consistent

00:05:35.759 --> 00:05:39.019
data. But how do you decide which experiments

00:05:39.019 --> 00:05:41.480
to run? Out of all the possibilities, that's

00:05:41.480 --> 00:05:44.459
where statistical design comes in, DOE. Yes,

00:05:44.699 --> 00:05:47.459
you've hit on a really key piece. Design of experiments,

00:05:47.639 --> 00:05:50.139
DOE. It gives you a smart strategy for planning

00:05:50.139 --> 00:05:52.519
these parallel runs. So not just random trial

00:05:52.519 --> 00:05:55.819
and error. No, no. It's systematic. DOE lets

00:05:55.819 --> 00:05:58.800
you very... multiple factors, temperature, concentration,

00:05:59.019 --> 00:06:01.459
time, whatever, all at once, but according to

00:06:01.459 --> 00:06:03.759
a specific efficient plan. Okay, so instead of

00:06:03.759 --> 00:06:05.560
changing just one thing, seeing what happens,

00:06:05.600 --> 00:06:08.439
changing another, you adjust several things together,

00:06:08.560 --> 00:06:10.899
systematically. What's the big win there? The

00:06:10.899 --> 00:06:14.199
win is efficiency and insight. By varying factors

00:06:14.199 --> 00:06:16.519
together, DOE helps you pinpoint the critical

00:06:16.519 --> 00:06:18.439
parameters, the ones that really drive the reaction

00:06:18.439 --> 00:06:20.740
outcome. The important levers to pull. Right.

00:06:21.060 --> 00:06:23.360
And crucially, how those parameters interact

00:06:23.360 --> 00:06:27.019
with each other. Which you often miss with a

00:06:27.019 --> 00:06:29.920
one factor at a time approach interactions. Okay,

00:06:30.019 --> 00:06:32.860
so you get a much deeper more comprehensive understanding

00:06:32.860 --> 00:06:37.050
of the process but with significantly fewer actual

00:06:37.050 --> 00:06:39.870
experiments. It adds statistical rigor. And that

00:06:39.870 --> 00:06:42.490
rigor helps build a robust process, something

00:06:42.490 --> 00:06:45.430
reliable. Exactly. Because robustness is what

00:06:45.430 --> 00:06:47.269
you need for manufacturing, isn't it? Yeah. You

00:06:47.269 --> 00:06:49.470
want a process that works consistently, even

00:06:49.470 --> 00:06:51.389
with the small variations you inevitably get

00:06:51.389 --> 00:06:54.250
in a real plant. Makes sense. So DOE helps you

00:06:54.250 --> 00:06:56.769
find not just the best conditions, highest yield,

00:06:57.209 --> 00:07:00.050
best purity, but also the acceptable range around

00:07:00.050 --> 00:07:02.509
those conditions, the operating window. So you

00:07:02.509 --> 00:07:04.389
know how much wiggle room you have. Precisely.

00:07:04.459 --> 00:07:06.800
And it also helps you understand and quantify

00:07:06.800 --> 00:07:09.819
variability in the process itself, which is key

00:07:09.819 --> 00:07:12.379
for ensuring consistent quality batch after batch.

00:07:13.040 --> 00:07:15.279
It connects back to needing consistency for reliable

00:07:15.279 --> 00:07:18.079
results, like in clinical trials. A well -understood

00:07:18.079 --> 00:07:21.259
process gives predictable outcomes. OK, so let's

00:07:21.259 --> 00:07:24.079
tie it all together. We have parallel synthesis,

00:07:24.680 --> 00:07:26.939
automated reactors, small -scale work, computer

00:07:26.939 --> 00:07:30.939
control, statistical design. How does this whole

00:07:30.939 --> 00:07:33.420
package speed up getting a drug from the lab

00:07:33.420 --> 00:07:36.980
bench to, well, to patients? Well, all that knowledge

00:07:36.980 --> 00:07:40.100
you gain early on from those small, controlled,

00:07:40.300 --> 00:07:43.339
statistically designed experiments, it directly

00:07:43.339 --> 00:07:45.980
fuels process optimization. You figure out the

00:07:45.980 --> 00:07:49.139
best way to make it much earlier. Yes. You identify

00:07:49.139 --> 00:07:51.480
efficient, robust conditions right at the start.

00:07:51.720 --> 00:07:53.839
So when it's time to scale up for manufacturing.

00:07:54.100 --> 00:07:56.279
Fewer nasty surprises. Less troubleshooting.

00:07:56.500 --> 00:07:59.000
Much less, ideally. Early optimization heads

00:07:59.000 --> 00:08:00.879
off many problems that might only show up at

00:08:00.879 --> 00:08:03.120
large scale. Some sources talk about the challenges

00:08:03.120 --> 00:08:05.480
of scale up, and this approach really tackles

00:08:05.480 --> 00:08:08.060
that proactively. And fundamentally, just being

00:08:08.060 --> 00:08:10.000
able to identify those optimal conditions so

00:08:10.000 --> 00:08:12.079
much faster drastically cuts down the overall

00:08:12.079 --> 00:08:14.180
development timeline. Moving from discovery to

00:08:14.180 --> 00:08:15.819
clinical trials can happen much more quickly.

00:08:16.139 --> 00:08:18.459
The small -scale insights really do inform and

00:08:18.459 --> 00:08:20.699
streamline those bigger pilot plant runs. OK,

00:08:20.740 --> 00:08:23.839
so to sum it up then, key takeaways on how these

00:08:23.839 --> 00:08:26.500
technologies accelerate development. I'd say,

00:08:26.720 --> 00:08:28.959
number one, a seriously compressed timeline,

00:08:29.220 --> 00:08:31.079
because you explore and optimize so rapidly,

00:08:31.540 --> 00:08:34.080
two, more efficient process optimization, leading

00:08:34.080 --> 00:08:37.120
to robust, reliable manufacturing methods, and

00:08:37.120 --> 00:08:41.200
three, improved scalability. That transition

00:08:41.200 --> 00:08:43.580
from lab bench to factory floor becomes much

00:08:43.580 --> 00:08:46.190
smoother, much faster. Ultimately, it sounds

00:08:46.190 --> 00:08:48.610
like these tools are directly tackling that urgent

00:08:48.610 --> 00:08:50.450
need, getting new treatments out there sooner.

00:08:51.009 --> 00:08:53.049
Absolutely. And with innovation constantly happening,

00:08:53.110 --> 00:08:54.889
like those new technology sections highlight,

00:08:55.230 --> 00:08:57.029
we can only expect these tools to get better

00:08:57.029 --> 00:09:00.190
and have an even bigger impact. So as you, our

00:09:00.190 --> 00:09:02.370
listener, think about all this, it really makes

00:09:02.370 --> 00:09:04.750
you wonder, doesn't it, how will pharma development

00:09:04.750 --> 00:09:07.110
keep evolving as these technologies get even

00:09:07.110 --> 00:09:09.750
smarter, even more widespread? What else might

00:09:09.750 --> 00:09:12.289
they unlock down the road? It's definitely a

00:09:12.289 --> 00:09:14.350
space to watch. Thanks for joining us for this

00:09:14.350 --> 00:09:14.870
deep dive.
